Hamming’s “open doors” and group creativity as keys to scientific excellence: The example of Cambridge

Magueijo, 2003 Max, 2002 Charlton, 2007, Scientometric identification of elite ‘revolutionary science’ research institutions by analysis of trends in Nobel prizes 1947–2006, Med Hypotheses, 68, 931, 10.1016/j.mehy.2006.12.006 University of Cambridge – The Nobel Prize. <http://www.cam.ac.uk/cambuniv/nobelprize.html>. Enterline, 1985, Evaluating cancer clusters, Am Ind Hyg Assoc J, 46, B10, 10.1080/15298668591394608 The Rand Corporation, 1955 Rothman, 1986, Significance questing, Ann Intern Med, 105, 445, 10.7326/0003-4819-105-3-445 Garcia GD. People. Time. 1986; Feb 24:69. <http://www.time.com/time/magazine/article/0,9171,960725,00.html>. Last accessed at May 3, 2007. Hamming R. You and your research. Transcription of the Bell Communications Research Colloquium Seminar, March 7 (1986) Provided by Kaiser JF, Bell Communications research. <http://www.cs.virginia.edu/~robins/YouAndYourResearch.html>. Erren, 2004, The quest for questions – on the logical force of science, Med Hypotheses, 62, 635, 10.1016/j.mehy.2003.10.022 Watson, 1968 Chargaff, 1974, Building the tower of Babble, Nature, 248, 776, 10.1038/248776a0 Watson JD. We wanted to answer the question: what is life?. James Watson in a February, 2003 Spiegel interview available in Spiegel 9/2003, p. 171. Watson, 2003 Erren, 2007, The case for a posteriori hypotheses to fuel scientific progress, Med Hypotheses, 69, 448, 10.1016/j.mehy.2006.12.026 Horrobin, 1975, Ideas in biomedical science: reasons for the foundation of Medical Hypotheses, Med Hypotheses, 1, 1, 10.1016/0306-9877(75)90032-8 What is PLoS One? A new way of communicating peer-reviewed science and medicine. <http://www.plosone.org/home.action>.